Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Fleming

Showing results (661-670 of 760) with videos related to

Pageof 76
Sort By:
Cancer|October 27, 2011
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcomeDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Journal of the American College of Surgeons|May 13, 2008
Borderline resectable pancreatic cancer: the importance of this emerging stage of diseaseMatthew H G Katz, Peter W T Pisters, Douglas B Evans, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancerAwalpreet S Chadha, Esengul Kocak-Uzel, Prajnan Das, et al.
The American Journal of Surgical Pathology|July 23, 2015
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal AdenocarcinomaLi Liu, Matthew H Katz, Sun M Lee, et al.
Biomaterials|January 15, 2018
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapyJun Zhao, Huamin Wang, Cheng-Hui Hsiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB ActivationZhuonan Zhuang, Huai-Qiang Ju, Mitzi Aguilar, et al.
Abdominal Radiology (New York)|November 22, 2019
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable diseaseNaveen M Kulkarni, Erik V Soloff, Parag P Tolat, et al.
Pancreas|September 14, 2017
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant ChemotherapyReza Nejati, Jennifer B Goldstein, Daniel M Halperin, et al.
JCO Precision Oncology|July 12, 2021
Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in <i>KRAS</i> Wild-Type Pancreatic CancerMichael J Fusco, Daryoush Saeed-Vafa, Estrella M Carballido, et al.
Nature Communications|June 30, 2026
Context-dependent interplay of Swi-Snf and Tup1-Cyc8 influences chromatin and transcription at antagonistically regulated genesXuyuan Guo, Mohamed M Alhussain, Brenda Lee, et al.
Pageof 76

Showing results (661-670 of 760) with videos related to

Sort By:
Pageof 76
Cancer|October 27, 2011
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcomeDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Journal of the American College of Surgeons|May 13, 2008
Borderline resectable pancreatic cancer: the importance of this emerging stage of diseaseMatthew H G Katz, Peter W T Pisters, Douglas B Evans, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancerAwalpreet S Chadha, Esengul Kocak-Uzel, Prajnan Das, et al.
The American Journal of Surgical Pathology|July 23, 2015
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal AdenocarcinomaLi Liu, Matthew H Katz, Sun M Lee, et al.
Biomaterials|January 15, 2018
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapyJun Zhao, Huamin Wang, Cheng-Hui Hsiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB ActivationZhuonan Zhuang, Huai-Qiang Ju, Mitzi Aguilar, et al.
Abdominal Radiology (New York)|November 22, 2019
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable diseaseNaveen M Kulkarni, Erik V Soloff, Parag P Tolat, et al.
Pancreas|September 14, 2017
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant ChemotherapyReza Nejati, Jennifer B Goldstein, Daniel M Halperin, et al.
JCO Precision Oncology|July 12, 2021
Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in <i>KRAS</i> Wild-Type Pancreatic CancerMichael J Fusco, Daryoush Saeed-Vafa, Estrella M Carballido, et al.
Nature Communications|June 30, 2026
Context-dependent interplay of Swi-Snf and Tup1-Cyc8 influences chromatin and transcription at antagonistically regulated genesXuyuan Guo, Mohamed M Alhussain, Brenda Lee, et al.
Pageof 76